Abstract
KEY POINTS
Postoperative hypocalcemia remains a frequent complication of total thyroidectomy.
Both routine prophylactic supplementation and parathyroid hormone-guided selective supplementation are safe and effective approaches to prevent and treat postoperative hypocalcemia.
Choice of approach may be guided by surgeon preference, institutional practices, and feasibility of timely postoperative parathyroid hormone assessment.
SUMMARY
Background
Postoperative hypocalcemia is one of the most frequent complications of total thyroidectomy, estimated to occur transiently in up to 30% of cases. 1 Various strategies exist to detect and manage postoperative hypocalcemia, with significant variability in practice across institutions and individuals. Current approaches generally involve either routine postoperative calcium supplementation (with or without calcitriol) or selective calcium supplementation (with or without calcitriol) guided by postoperative parathyroid hormone (PTH) levels. Evidence supports both approaches, and each carries important trade-offs related to cost, feasibility, and clinical risks. This study 2 is the first randomized controlled trial providing a direct comparison of clinical outcomes with routine versus selective supplementation.
Methods
This was a multicenter diagnostic randomized controlled trial investigating routine versus PTH-guided selective use of postoperative calcium and calcitriol in patients undergoing total or completion thyroidectomy. Participants were randomly assigned to receive either prophylactic calcium carbonate (1200 mg every 8 hours) with calcitriol (0.25 µg every 12 hours) or to receive this supplementation regimen only if the PTH value obtained 4 hours postoperatively was less than 15 pg/mL. The primary outcome was the occurrence of symptomatic hypocalcemia within 15 days postoperatively. A modified validated symptom scale (Hypoparathyroid Patient Questionnaire) was used to minimize the subjectivity of reporting. Secondary outcomes included biochemical hypocalcemia (defined as serum calcium < 8 mg/dL) or PTH < 15 pg/mL on postoperative day 15, adverse events associated with administration of calcium/calcitriol, need for unplanned postoperative calcium/calcitriol supplementation, surgical complications, and readmission for hypocalcemia.
Results
A total of 330 patients underwent randomization, with 117 in the routine supplementation group and 141 in the selective supplementation group included in the final analysis. No difference in the occurrence of symptomatic hypocalcemia was observed (7.8% in the selective supplementation group vs. 11.1% in the routine supplementation group; odds ratio [OR], 0.68; 95% confidence interval [CI], 0.29–1.57; p = 0.36). A subgroup analysis of 148 patients with complete serum data showed no difference in occurrence of biochemical hypocalcemia (21.6% in the PTH-guided group versus 17.6% in the routine supplementation group; OR, 1.29; 95% CI, 0.57–2.93; p = 0.53). No differences in adverse events or complications were observed.
Conclusions
In adults undergoing total or completion thyroidectomy, routine prophylactic calcium/calcitriol supplementation and PTH-directed supplementation demonstrate similar efficacy and safety in preventing both symptomatic and biochemical hypocalcemia.
COMMENTARY
Hypocalcemia remains a common complication after total thyroidectomy, even in experienced surgical hands. 3 As thyroid surgery increasingly shifts to the ambulatory setting, the implementation of safe and effective protocols for the prevention and management of postoperative hypocalcemia is ever more critical, given the limited opportunity for postoperative monitoring and intervention. 4
Routine prophylactic administration of calcium supplementation with or without calcitriol is a cost-effective approach for prevention of postoperative hypocalcemia, though it carries some risk for the development of hypercalcemia. A phase 2 trial examined preoperative use of calcitriol versus placebo for prevention of postoperative hypocalcemia, with all patients receiving postoperative routine prophylactic calcium and calcitriol supplementation. 5 Among 51 patients, 6 (11.7%), including 2 in the placebo group, experienced postoperative hypercalcemia, with 1 patient developing severe (grade 3) hypercalcemia that responded to discontinuation of supplementation. In a recently published update on ambulatory thyroid surgery, the American Thyroid Association advises careful biochemical monitoring when calcitriol is administered in order to avoid hypercalcemia and potential renal injury. 4
Selective calcium/calcitriol supplementation guided by postoperative PTH assessment is an alternative strategy that may reduce unnecessary treatment, but it incurs additional costs and may not be readily available in all practice settings. Studies have consistently shown that postoperative PTH < 15 pg/mL is strongly associated with the development of hypocalcemia and that patients with PTH > 15 pg/mL measured at least 20 minutes after surgery can safely forgo serum calcium monitoring and prophylactic supplementation. 4 It is important in this setting to educate patients on symptoms of hypocalcemia, as severe hypocalcemia may be associated with significant complications, including arrhythmia and seizure. In my own surgical practice, I employ PTH-guided selective supplementation and advise patients who are not receiving supplementation to take 1–2 TUMS (500 g of calcium carbonate each) should mild symptoms of hypocalcemia develop, such as perioral or digital numbness/tingling.
This randomized controlled trial by Garcia-Lozano et al. is the first of its kind to directly compare these approaches, demonstrating no difference in symptomatic or biochemical postoperative hypocalcemia and no differences in treatment-related adverse events. These findings suggest that either strategy can be safely employed, with the choice guided by surgeon preference, institutional practice patterns, and the availability and cost of timely postoperative PTH assessment. Clinical judgment, patient education, and communication remain central to the safe implementation of these practices.